BERNARDSVILLE, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader in Visual Biology for drug discovery, will showcase its Lightning AI platform at the 3 rd annual ...

BERNARDSVILLE, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, announced today positive preclinical data of its lung fibrosis candidate. This ...

BERNARDSVILLE, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, today announced their participation in the upcoming 6 th Annual ...

Anima Biotech Inc. has released promising preclinical data on its new candidate, which has potential for treating idiopathic pulmonary fibrosis (IPF).

BERNARDSVILLE, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leading Tech.Bio in the discovery of mRNA drugs and targets, announced its third webinar, a part of their exclusive LightON ...

BERNARDSVILLE, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven ...